Showing results (91-100 of 259) with videos related to
Sort By:
Pageof 26
Therapeutic Drug Monitoring|September 14, 2011
Therapeutic drug monitoring for drugs used in the treatment of substance-related disorders: literature review using a therapeutic drug monitoring appropriateness rating scaleSonja Brünen, Philippe D Vincent, Pierre Baumann, et al.Frontiers in Behavioral Neuroscience|March 10, 2012
Preventive role of social interaction for cocaine conditioned place preference: correlation with FosB/DeltaFosB and pCREB expression in rat mesocorticolimbic areasRana El Rawas, Sabine Klement, Ahmad Salti, et al.Behavioural Pharmacology|February 25, 2016
Dyadic social interaction of C57BL/6 mice versus interaction with a toy mouse: conditioned place preference/aversion, substrain differences, and no development of a hierarchyBarbara S Pinheiro, Simon S Seidl, Eva Habazettl, et al.Pharmacology|September 29, 2012
Acetylcholine, drug reward and substance use disorder treatment: intra- and interindividual striatal and accumbal neuron ensemble heterogeneity may explain apparent discrepant findingsJanine M Prast, Kai K Kummer, Constanze M Barwitz, et al.Drugs - Real World Outcomes|June 12, 2021
Risk of Bleeding Associated with Antidepressant Drugs: The Competitive Impact of Antithrombotics in Quantitative Signal DetectionRené Zeiss, Christoph Hiemke, Carlos Schönfeldt-Lecuona, et al.The Journal of Clinical Psychiatry|September 8, 2018
Differences in Duloxetine Dosing Strategies in Smoking and Nonsmoking Patients: Therapeutic Drug Monitoring Uncovers the Impact on Drug MetabolismMarc Augustin, Georgios Schoretsanitis, Christoph Hiemke, et al.Journal of Psychiatric Research|December 6, 2005
Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophreniaMatthias J Müller, Boris Regenbogen, Sebastian Härtter, et al.Schizophrenia Research|December 21, 2016
Effect of smoking on risperidone pharmacokinetics - A multifactorial approach to better predict the influence on drug metabolismGeorgios Schoretsanitis, Ekkehard Haen, Benedikt Stegmann, et al.Psychopharmacology|June 3, 2015
Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levelsGudrun Hefner, Mohamed E E Shams, Stefan Unterecker, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 28, 2018
Reduced clearance of venlafaxine in a combined treatment with quetiapineMichael Paulzen, Georgios Schoretsanitis, Christoph Hiemke, et al.Pageof 26